In the news release, Amgen To Present At The Goldman Sachs 39th
Annual Global Healthcare Conference, issued 07-Jun-2018 by Amgen over PR Newswire, we are
advised by the company that the 1st paragraph, 1st sentence, should
read "Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 39th
Annual Global Healthcare Conference at 1:20
p.m. PT on Tuesday, June 12, 2018, in Rancho Palos Verdes, Calif." rather than
"Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 39th Annual
Global Healthcare Conference at 9:30 a.m. PT
on Tuesday, June 12, 2018, in Rancho Palos Verdes, Calif." as originally
issued inadvertently. The complete, corrected release follows:
Amgen To Present At The Goldman Sachs 39th Annual Global Healthcare
Conference
THOUSAND OAKS, Calif.,
June 7, 2018 /PRNewswire/
-- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs
39th Annual Global Healthcare Conference at 1:20 p.m. PT on Tuesday, June 12, 2018, in
Rancho Palos Verdes, Calif.
Elliott M. Levy, M.D., senior vice
president of Research and Development at Amgen, will present at the
conference. Live audio of the presentation can be accessed from the
Events Calendar on Amgen's website, www.amgen.com, under Investors.
A replay of the webcast will also be available on Amgen's website
for at least 90 days following the event.
About Amgen
Amgen is committed to unlocking the
potential of biology for patients suffering from serious illnesses
by discovering, developing, manufacturing and delivering innovative
human therapeutics. This approach begins by using tools like
advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the world's leading
independent biotechnology companies, has reached millions of
patients around the world and is developing a pipeline of medicines
with breakaway potential.
For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Kristen Davis, 805-447-3008
(media)
Kristen Neese, 805-313-8267
(media)
Arvind Sood, 805-447-1060
(investors)
View original content with
multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-goldman-sachs-39th-annual-global-healthcare-conference-300661551.html
SOURCE Amgen